Skip to the stories
Wednesday, 18 November 2026
Saved
FTMQ News

Next edition

0:59

Headlines

Top Stories

White House withdraws Heidi Overton nomination as FDA commissioner

The Trump administration has withdrawn its nomination of Dr. Heidi Overton to lead the Food and Drug Administration ahead of a planned Senate committee vote.

FTMQ News, written by our newsroom1 view

Share
Picture: UPI

The Trump administration has dropped the nomination of Dr. Heidi Overton to lead the U.S. Food and Drug Administration, as reported by UPI, the Guardian, the Washington Examiner, and The Hill. Multiple news outlets, including Axios, CNN, and NBC News, reported that the White House withdrew her name because of opposition in Congress. A senior White House official confirmed to Axios that Overton lacked the support needed on Capitol Hill to proceed with her confirmation. [1][2][3][5]

The White House decision came one day before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on Wednesday on whether to advance her nomination to the full Senate. A White House official confirmed to the Washington Examiner on Tuesday that the nomination had been pulled. The Washington Post also reported that the decision followed bipartisan pushback. [1][2][3][7]

President Donald Trump originally nominated Overton, a physician and prominent opponent of abortion, in August, according to the Guardian. The outlet noted that Overton has spent most of her career working directly for Trump or for conservative organizations aligned with his agenda. Meanwhile, the Washington Examiner reported that supporters of Health and Human Services Secretary Robert F. Kennedy Jr.'s movement criticized Overton for not assisting with his priorities. [2][3]

Share

In short

  • The White House dropped the nomination of Dr. Heidi Overton to lead the Food and Drug Administration.
  • The decision occurred a day before the Senate Health, Education, Labor and Pensions Committee was set to vote on her nomination.
  • Donald Trump nominated Dr. Heidi Overton to the FDA post in August.
  • Media outlets reported the withdrawal was caused by congressional opposition and pushback.

Sources

Every paragraph above points to the numbered items it rests on. Read the originals here.

  1. [1]Reports: White House drops Overton as FDA leader nomineeUPI, 3h ago (the report this story comes from)
  2. [2]White House withdraws nomination of Heidi Overton to lead FDAThe Guardian, 3h ago
  3. [3]White House withdraws Heidi Overton’s nomination to become next FDA commissionerwashingtonexaminer.com, 3h ago
  4. [4]White House withdraws Heidi Overton’s nomination to become next FDA commissionerWashington Examiner, 3h ago
  5. [5]White House pulls nomination of Heidi Overton to lead FDAThe Hill, 4h ago
  6. [6]White House pulls nomination of Heidi Overton to lead FDAThe Hill, 4h ago
  7. [7]White House pulls FDA nominee amid bipartisan pushbackThe Washington Post, 4h ago
  8. [8]Exclusive / Trump administration weighs Marshall for FDA as Overton wobblesSemafor, 14h ago
  9. [9]White House Pulls FDA Chief Nominee Before Hearing, Axios SaysBloomberg.com, 4h ago
  10. [10]White House pulls nomination of Dr. Heidi Overton to lead the FDA | ITV NewsITVX, 4h ago

Background

  1. [11]White House on Wikipedia
  2. [12]2026 United States Senate election in Maine on Wikipedia
  3. [13]2028 United States presidential election on Wikipedia
  4. [14]White House on Grokipedia
  5. [15]Michigan Democratic Senate candidate faces criticism from Black leader and primary rival FTMQ News, 17d ago
  6. [16]Zionist leader criticises Democratic candidate over Michigan Senate debate comments FTMQ News, 30d ago

Our newsroom writes these reports with the help of software, from the 16 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.

Earlier reports of ours on the same people and subjects.

More in Top Stories

Get the day in one email

Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments

Loading

Join the conversation

Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.

Already on the list? Enter the same address and we will send a sign-in link.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.